Appetite & Satiety
Reference materials for in-vitro research on hypothalamic and gut-derived pathways involved in appetite regulation and meal termination.
For Research Use Only
This brief describes analytical reference materials supplied by R3TA LLC for in-vitro laboratory research. It is not a protocol and contains no dosing, administration, or therapeutic guidance. Not for human or animal consumption.
GLP-3 has been linked to reduced food intake and increased satiety signaling in preclinical models through combined GLP-1, GIP, and glucagon receptor activity.
R3TA reference materials support neuronal and enteroendocrine cell assays of appetite-regulating peptide release and receptor activation.
For Research Purpose Only; no claim of appetite-suppressant effect in humans.
Representative in-vitro endpoints
- —Hypothalamic neuronal cAMP and calcium-flux responses
- —Enteroendocrine cell GLP-1, CCK, and PYY release endpoints
- —Receptor internalization and β-arrestin recruitment imaging
- —Brain-slice explant neuropeptide expression profiling
Handling & storage
- —Store lyophilized at −20 °C, desiccated
- —Reconstitute aseptically and aliquot
- —Limit reconstituted storage duration
- —Log lot numbers with each experiment
Analytical documentation
- —RP-HPLC purity report
- —LC-MS identity confirmation
- —Counter-ion content available on request